NME1 and cancer: EBV-derived nuclear antigen 1 and nuclear protein EBNA-3C both interact with NME1 and reverse the metastasis-suppressive activity of NME1, indicating that these EBV proteins target and antagonize the functions of NME1 to promote cancer metastasis7,8.